Immune Cell Replenishment

About Alpha-1 Biologics

Alpha-1 Biologics is a pre-clinical stage biotech leveraging foundational research from its founder, Dr. Cynthia L. Bristow, to develop oral therapies that modulate immune cell trafficking. The company's core technology aims to generate immune cells from stem cells within the body, targeting significant unmet needs in cancer immunotherapy and primary/secondary immunodeficiencies. It has been historically funded by non-profit research organizations but appears to be a private, early-stage venture with a pipeline yet to enter clinical trials. The leadership brings deep academic and clinical immunology expertise, though the company's operational scale and recent funding trajectory are not publicly detailed.

Therapeutic Areas